article

The role of packaging in improving the bottom line for big pharma

Rich Quelch, Global Head of Marketing at DiD,1 explores how packaging can help pharma to cut costs, uphold high quality standards and improve health outcomes.

Boosting the bottom line is often associated with a decrease in product and delivery quality, with manufacturers turning to more cost-effective material alternatives and skipping steps in the supply chain. However, the Consumer Packaged Goods (CPG) sector bucks this trend, with businesses experiencing financial success while cutting costs in a competitive and fast-paced industry.

We are now seeing this trend making its way into the pharma space. With mounting ethical pressures on big pharma, including those to make sustainable changes, it is more important than ever for businesses to get in the green – in more ways than one. Packaging plays a key role in all aspects of the pharma supply chain, from production, manufacturing and delivery to patient consumption. As such, streamlining the packaging process can have a significant impact on a business’ financial success.

Send this to a friend